Retinapohjan

Retinapohjan, also known as retinopathy of prematurity (ROP), is a condition that affects premature infants. It occurs when the blood vessels in the retina, the light-sensitive tissue at the back of the eye, grow too quickly and become abnormal. This can lead to retinal detachment, which can cause permanent vision loss if left untreated.

ROP is more common in infants born before 32 weeks of gestation. The risk of developing ROP increases with lower gestational age and higher birth weight. The condition is typically diagnosed using specialized eye examinations, such as indirect ophthalmoscopy or ultrasound.

Treatment for ROP usually involves laser therapy or cryotherapy, which are used to stop the abnormal blood vessel growth. The goal of treatment is to preserve the infant's vision and prevent retinal detachment. In some cases, surgery may be necessary to repair the retina.

Prevention of ROP involves maintaining a stable oxygen level in the infant's environment and avoiding excessive oxygen exposure. Regular eye examinations are also important to detect and treat ROP early.

ROP is a serious condition that can have long-term effects on a child's vision. Early detection and treatment are crucial for preventing permanent vision loss.